For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Health Care & Hospital Law,
Government

Apr. 21, 2022

San Francisco settles opioid case for $10M on eve of trial

With Endo International now removed, the group of corporate defendants will be: Walgreens, Allergan, Teva, and Anda, opposing a demand for relief of $8 billion in a bench trial starting Monday.

San Francisco City Attorney David Chiu announced a $10 million settlement with Endo International on Wednesday ahead of the city’s historic trial next week against multiple opioid distributors.

The settlement, agreed to in principle, severs Endo International as a defendant from the trial set to begin on Monday and gives the City of San Francisco $5 million immediately to address symptoms of the opioid epidemic. The other $5 million will b...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.